4.5 Article

Changes in hepatitis B vaccine perception in response to the COVID-19 pandemic: Development of the Shift in vaccine confidence (SVC) survey tool

期刊

VACCINE
卷 41, 期 3, 页码 623-629

出版社

ELSEVIER SCI LTD
DOI: 10.1016/j.vaccine.2022.12.028

关键词

hepatitis B virus vaccine; COVID-19 vaccine; Vaccine hesitancy; Survey tool

资金

  1. Gilead Sciences, Inc [ISR-US-18-10486]
  2. American Society for Tropical Medicine and Hygiene (ASTMH)/Burroughs-Wellcome Fund
  3. National Center for Advancing Translational Sciences (NCATS), National Institutes of Health [UL1TR002489]
  4. NIH [K08AI148607]

向作者/读者索取更多资源

This study describes the development of an assessment tool in Kinshasa, Democratic Republic of Congo, to evaluate the impact of the COVID-19 pandemic on routine vaccinations, with a focus on the HBV vaccine. Through three rounds of stakeholder feedback, the research team improved the readability and clarity of the survey tool.
The COVID-19 pandemic has disrupted access to, adherence to, and perceptions of routine vaccinations. We developed the Shift in Vaccine Confidence (SVC) survey tool to assess the impact of the pandemic on routine vaccinations, with a focus on the HBV vaccine, in Kinshasa, Democratic Republic of Congo (DRC). This study describes the content validation steps we conducted to ensure the survey tool is meaningful to measure changes in vaccine confidence to regular immunization (HBV vaccine) due to the pandemic. Three rounds of stakeholder feedback from a DRC-based study team, content and measurement experts, and study participants allowed us to produce a measure with improved readability and clarity.(c) 2022 Elsevier Ltd. All rights reserved.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.5
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据